A detailed history of Geode Capital Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,873,927 shares of ALKS stock, worth $115 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,873,927
Previous 3,933,964 1.53%
Holding current value
$115 Million
Previous $94.8 Million 14.37%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$23.01 - $28.55 $1.38 Million - $1.71 Million
-60,037 Reduced 1.53%
3,873,927 $108 Million
Q2 2024

Aug 09, 2024

BUY
$23.21 - $27.24 $4.44 Million - $5.21 Million
191,193 Added 5.11%
3,933,964 $94.8 Million
Q1 2024

May 13, 2024

BUY
$26.4 - $32.56 $2.76 Million - $3.41 Million
104,682 Added 2.88%
3,742,771 $101 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $3.8 Million - $4.66 Million
162,395 Added 4.67%
3,638,089 $101 Million
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $3.78 Million - $4.45 Million
139,251 Added 4.17%
3,475,694 $97.4 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $4.6 Million - $5.46 Million
162,409 Added 5.12%
3,336,443 $104 Million
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $3.3 Million - $3.78 Million
130,271 Added 4.28%
3,174,034 $89.5 Million
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $2.02 Million - $2.41 Million
91,847 Added 3.11%
3,043,763 $79.5 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $1.62 Million - $2.34 Million
73,508 Added 2.55%
2,951,916 $65.9 Million
Q2 2022

Aug 12, 2022

BUY
$26.4 - $30.54 $280,024 - $323,937
10,607 Added 0.37%
2,878,408 $85.7 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $92,326 - $112,015
-4,002 Reduced 0.14%
2,867,801 $75.5 Million
Q4 2021

Feb 11, 2022

BUY
$21.47 - $32.08 $1.32 Million - $1.97 Million
61,474 Added 2.19%
2,871,803 $66.8 Million
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $5.79 Million - $7.96 Million
-247,610 Reduced 8.1%
2,810,329 $86.7 Million
Q2 2021

Aug 13, 2021

BUY
$18.78 - $25.15 $15.3 Million - $20.5 Million
815,113 Added 36.34%
3,057,939 $75 Million
Q1 2021

May 12, 2021

BUY
$18.21 - $23.2 $4.09 Million - $5.21 Million
224,559 Added 11.13%
2,242,826 $41.9 Million
Q4 2020

Feb 12, 2021

BUY
$15.39 - $22.1 $2.82 Million - $4.05 Million
183,291 Added 9.99%
2,018,267 $40.3 Million
Q3 2020

Nov 13, 2020

SELL
$16.16 - $20.66 $1.2 Million - $1.54 Million
-74,305 Reduced 3.89%
1,834,976 $30.4 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $19.41 $319,253 - $465,568
23,986 Added 1.27%
1,909,281 $37 Million
Q1 2020

May 14, 2020

BUY
$13.06 - $21.24 $1.09 Million - $1.78 Million
83,683 Added 4.64%
1,885,295 $27.2 Million
Q4 2019

Feb 13, 2020

SELL
$17.29 - $21.74 $91,412 - $114,939
-5,287 Reduced 0.29%
1,801,612 $36.8 Million
Q3 2019

Nov 12, 2019

BUY
$19.51 - $24.28 $563,019 - $700,672
28,858 Added 1.62%
1,806,899 $35.2 Million
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $3.4 Million - $5.91 Million
158,433 Added 9.78%
1,778,041 $40.1 Million
Q1 2019

May 14, 2019

BUY
$28.4 - $36.49 $2.08 Million - $2.68 Million
73,353 Added 4.74%
1,619,608 $59.1 Million
Q4 2018

Feb 13, 2019

BUY
$27.94 - $44.61 $2.14 Million - $3.42 Million
76,621 Added 5.21%
1,546,255 $45.6 Million
Q3 2018

Nov 13, 2018

BUY
$38.6 - $46.12 $1.33 Million - $1.59 Million
34,470 Added 2.4%
1,469,634 $62.3 Million
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $2.15 Million - $2.72 Million
52,916 Added 3.83%
1,435,164 $59 Million
Q1 2018

May 15, 2018

BUY
$53.61 - $67.26 $2.62 Million - $3.28 Million
48,819 Added 3.66%
1,382,248 $80.1 Million
Q4 2017

Feb 13, 2018

BUY
$47.69 - $55.39 $1.03 Million - $1.2 Million
21,608 Added 1.65%
1,333,429 $72.9 Million
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $1.17 Million - $1.3 Million
23,801 Added 1.85%
1,311,821 $66.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,288,020
1,288,020 $74.6 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.